Peep V. Algvere
Karolinska Institutet
St. Eriks Eye Hospital
Stockholm
Sweden
Name/email consistency: high
- Visual improvement in central retinal vein occlusion (CRVO) following intravitreal injections of bevacizumab (Avastin(®) ). Algvere, P.V., Von Wendt, G., Gudmundsson, J., Seregard, S., Kvanta, A. Acta. Ophthalmol (2010)
- A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations. Algvere, P.V., Steén, B., Seregard, S., Kvanta, A. Acta. Ophthalmol (2008)
- Age-related maculopathy and the impact of blue light hazard. Algvere, P.V., Marshall, J., Seregard, S. Acta. Ophthalmol. Scand (2006)
- Transpupillary thermotherapy of predominantly occult choroidal neovascularization in age-related macular degeneration with 12 months follow-up. Algvere, P.V., Libert, C., Lindgärde, G., Seregard, S. Acta. Ophthalmol. Scand (2003)
- Age-related maculopathy: pathogenetic features and new treatment modalities. Algvere, P.V., Seregard, S. Acta. Ophthalmol. Scand (2002)
- Transpupillary thermotherapy of occult CNV with no or minimally classic CNV in age-related macular degeneration. Algvere, P.V., Libert, C., Seregard, S. Semin. Ophthalmol (2001)